CO5070587A1 - Terapia de combinacion para la fragilidad musculoesqueletica - Google Patents

Terapia de combinacion para la fragilidad musculoesqueletica

Info

Publication number
CO5070587A1
CO5070587A1 CO99037622A CO99037622A CO5070587A1 CO 5070587 A1 CO5070587 A1 CO 5070587A1 CO 99037622 A CO99037622 A CO 99037622A CO 99037622 A CO99037622 A CO 99037622A CO 5070587 A1 CO5070587 A1 CO 5070587A1
Authority
CO
Colombia
Prior art keywords
fragility
compositions
combination therapy
oxo
pharmaceutically acceptable
Prior art date
Application number
CO99037622A
Other languages
English (en)
Spanish (es)
Inventor
Hua Zhu Ke
Li Mei
Pan Lydia Codetta
Thompson David Duane
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of CO5070587A1 publication Critical patent/CO5070587A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CO99037622A 1998-06-16 1999-06-16 Terapia de combinacion para la fragilidad musculoesqueletica CO5070587A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
CO5070587A1 true CO5070587A1 (es) 2001-08-28

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99037622A CO5070587A1 (es) 1998-06-16 1999-06-16 Terapia de combinacion para la fragilidad musculoesqueletica

Country Status (30)

Country Link
EP (1) EP1087764A1 (de)
JP (1) JP2002518326A (de)
KR (1) KR20010052852A (de)
CN (1) CN1301160A (de)
AP (1) AP9901582A0 (de)
AR (1) AR018869A1 (de)
AU (1) AU4054799A (de)
BG (1) BG105041A (de)
BR (1) BR9911324A (de)
CA (1) CA2335134A1 (de)
CO (1) CO5070587A1 (de)
EA (1) EA200001186A1 (de)
GT (1) GT199900087A (de)
HN (1) HN1999000097A (de)
HR (1) HRP20000859A2 (de)
HU (1) HUP0102505A3 (de)
ID (1) ID27599A (de)
IL (1) IL138630A0 (de)
IS (1) IS5691A (de)
MA (1) MA26652A1 (de)
NO (1) NO20006312L (de)
OA (1) OA11505A (de)
PA (1) PA8475901A1 (de)
PE (1) PE20000646A1 (de)
PL (1) PL344981A1 (de)
SK (1) SK18912000A3 (de)
TN (1) TNSN99124A1 (de)
TR (1) TR200003544T2 (de)
WO (1) WO1999065486A1 (de)
ZA (1) ZA993975B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2360103A1 (en) * 1999-02-08 2000-08-17 Robert Sladek Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
ATE346159T1 (de) 2000-05-08 2006-12-15 Pfizer Prod Inc Enzymatische spaltung von selektiven modulatoren des östrogenrezeptors
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EA200901077A1 (ru) 2007-02-09 2010-04-30 Транзим Фарма, Инк. Макроциклические модуляторы грелинового рецептора и их применение

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
AU4054799A (en) 2000-01-05
HRP20000859A2 (en) 2001-04-30
HUP0102505A3 (en) 2002-12-28
EP1087764A1 (de) 2001-04-04
MA26652A1 (fr) 2004-12-20
CN1301160A (zh) 2001-06-27
BG105041A (en) 2001-08-31
PE20000646A1 (es) 2000-08-05
TNSN99124A1 (fr) 2005-11-10
SK18912000A3 (sk) 2001-10-08
BR9911324A (pt) 2001-04-03
CA2335134A1 (en) 1999-12-23
HUP0102505A2 (hu) 2001-11-28
IL138630A0 (en) 2001-10-31
AR018869A1 (es) 2001-12-12
EA200001186A1 (ru) 2001-06-25
AP9901582A0 (en) 1999-06-30
NO20006312D0 (no) 2000-12-12
ZA993975B (en) 2000-12-15
OA11505A (en) 2004-05-07
GT199900087A (es) 2000-12-07
IS5691A (is) 2000-10-27
WO1999065486A1 (en) 1999-12-23
HN1999000097A (es) 1999-11-03
JP2002518326A (ja) 2002-06-25
KR20010052852A (ko) 2001-06-25
TR200003544T2 (tr) 2001-04-20
PL344981A1 (en) 2001-11-19
NO20006312L (no) 2000-12-12
PA8475901A1 (es) 2000-05-24
ID27599A (id) 2001-04-12

Similar Documents

Publication Publication Date Title
DE60037836D1 (de) ThiazoloÄ4,5-dÜpyrimidinverbindungen zur Behandlung von rheumathoider Arthritis
BR9714155A (pt) Prevenção da perda e reposição da massa óssea por certos agonistas de prostaglandina.
NO972043L (no) Tienopyridin eller tienopyrimidinderivater og deres anvendelse
YU18400A (sh) Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja
LU91710I2 (fr) Pazopanib, facultativement sous forme d'un sel ou d'un solvate pharmaceutiquement acceptable de celui-ci
ATE329540T1 (de) Knochenplatte zur fixation von proximalen humerusfrakturen
AU2001258138A1 (en) Bone plate for the fixation of fractures of the proximal humerus
SG148037A1 (en) Fgf variants and methods for use thereof
ATE250063T1 (de) Pyrazolopyrimidinone, cgmp pde5 inhibitoren, zur behandlung von sexuellen funktionsstörungen
GB0223040D0 (en) Therapeutic compounds
NO962127D0 (no) Isoksakinforbindelser som anti-innflammatoriske midler
ZA9810735B (en) Novel benzenesulfonamide inhibitors of pde-iv and their therapeutic use
BR0105457A (pt) Combinações terapêuticas para estimulação do crescimento ósseo
CO5070587A1 (es) Terapia de combinacion para la fragilidad musculoesqueletica
CO5070584A1 (es) Composicion farmaceutica que comprende (-)-cis-6-fenil-5-(4- (2-pirrolidin-1-il-etoxi)-fenil)-5,6,7,8-tetrahidronaftalen -2-ol y hormona paratiroidea
WO2005011721A3 (en) Use of a pak inhibitor for the treatment of a joint disease
CO5070586A1 (es) Combinaciones terapeuticas para la fragilidad musculoesque- letica
AU5548801A (en) Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
BR0206687A (pt) Método para prevenir e tratar dores viscerais e distúrbios gastrointestinais
BRPI0411168A (pt) composição para o tratamento dos cabelos, usos de uma composição e método de tratamento dos cabelos
ECSP993020A (es) Terapia de combinacion para la fragilidad musculoesqueletica
GB0026114D0 (en) New use
ECSP993021A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
PT966968E (pt) Combinacoes terapeuticas compreendendo um modulador de receptor de estrogenio selectivo e prostaglandina e2
ITRM20010092A1 (it) Placche e viti d'osso corticale, di origine animale, per fissaggio divertebre.